TSTL.LSE Tristel

Healthcare Health Care Equipment & Supplies London Exchange
4.05 GBX
Close of Nov 3, 2026
337.67 450.00
Market cap
GBX 195M
P/E
23.8x
P/B
5.45x
ROE
22.4%
Dividend yield
3.51%
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is TSTL.LSE undervalued?

Graham number
Price4.05
Graham value1.69
Premium140.3%

TSTL.LSE trades 140.3% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Tristel fundamental analysis

No fundamental analysis for Tristel yet.

Tristel stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Tristel

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surf…

Full company profile